Correlation Between Dyne Therapeutics and Protara Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dyne Therapeutics and Protara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyne Therapeutics and Protara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyne Therapeutics and Protara Therapeutics, you can compare the effects of market volatilities on Dyne Therapeutics and Protara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyne Therapeutics with a short position of Protara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyne Therapeutics and Protara Therapeutics.

Diversification Opportunities for Dyne Therapeutics and Protara Therapeutics

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Dyne and Protara is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and Protara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protara Therapeutics and Dyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyne Therapeutics are associated (or correlated) with Protara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protara Therapeutics has no effect on the direction of Dyne Therapeutics i.e., Dyne Therapeutics and Protara Therapeutics go up and down completely randomly.

Pair Corralation between Dyne Therapeutics and Protara Therapeutics

Considering the 90-day investment horizon Dyne Therapeutics is expected to generate 3.17 times less return on investment than Protara Therapeutics. In addition to that, Dyne Therapeutics is 1.07 times more volatile than Protara Therapeutics. It trades about 0.08 of its total potential returns per unit of risk. Protara Therapeutics is currently generating about 0.27 per unit of volatility. If you would invest  234.00  in Protara Therapeutics on August 31, 2024 and sell it today you would earn a total of  70.00  from holding Protara Therapeutics or generate 29.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Dyne Therapeutics  vs.  Protara Therapeutics

 Performance 
       Timeline  
Dyne Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Dyne Therapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Protara Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Protara Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Protara Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Dyne Therapeutics and Protara Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dyne Therapeutics and Protara Therapeutics

The main advantage of trading using opposite Dyne Therapeutics and Protara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyne Therapeutics position performs unexpectedly, Protara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protara Therapeutics will offset losses from the drop in Protara Therapeutics' long position.
The idea behind Dyne Therapeutics and Protara Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm